China’s unwavering determination in protecting pregnancy and perinatal health  

作　　者：Haitong Zhe Sun Qingyi Xiang Siyuan Xu Haizhen Dai Jing Fang Hao Tang Tao Xue Haikun Wang Kun Tang Yuming Guo Xiaoxia Bai 

机构地区：[1]Department of Obstetrics,Women’s Hospital,School of Medicine,Zhejiang University,Hangzhou 310006,China [2]Yusuf Hamied Department of Chemistry,University of Cambridge,Cambridge CB21EW,UK [3]School of Clinical Medicine,University of Cambridge,Cambridge CB20SP,UK [4]Institute of Reproductive and Child Health,National Health Commission Key Laboratory of Reproductive Health,Peking University,Beijing 100191,China [5]School of Atmospheric Sciences,Nanjing University,Nanjing 210023,China [6]Vanke School of Public Health,Tsinghua University,Beijing 100084,China [7]School of Public Health and Preventive Medicine,Monash University,Melbourne,VIC 3004,Australia [8]Key Laboratory of Women’s Reproductive Health,Hangzhou 310006,China

出　　处：《The Innovation》2022年第6期35-36,共2页创新（英文）

基　　金：supports in the establishment of ZEBRA.Research receives funding from Zhejiang Province Health Innovative Talent Project(A0466)and International Cooperation Seed ProgramofWomen’s Hospital,Zhejiang University(GH2022B008-01).

摘　　要：ACHIEVEMENTS AND CHALLENGES Before the advent ofmodern medicine,childbirth carried extremely high risk of mortality,both maternal and perinatal(the period beginning at the 20–28th week of gestation and ending at 1–4 weeks after delivery).Fortunately,with advances in prenatal healthcare,the prevalence of maternal and perinatal mortalities has significantly reduced.A press conference held on May 30,2022,by the National Health Commission of the People’s Republic of China,reviewed the major progress and achievements in Chinese maternal and child health over the past decade.It highlighted that the maternal mortality rate dropped to 161 per million in 2021,the lowest level in recorded history.

关 键 词：MORTALITY PREGNANCY MATERNAL 

分 类 号：R714[医药卫生—妇产科学]